Furthermore, SLC2A1, ENO1, LDHA and PDK1 mRNA levels were high in AD patients (Supplementary Fig. 7a), and we found significant negative correlation between RNF20 levels and SLC2A1, ENO1, LDHA and VEGFA expression (Supplementary Fig. 7b). This evidence concerns the gene SLC2A1 and Alzheimer disease.